공지사항 - 아이리움의 새로운 소식을 확인해 보세요.

NOTICE & NEWS

EYEREUM OPHTHALMIC CLINIC

ESCRS 37TH CONGRESS OF THE ESCRS PARIS

OCULUS - PENTACAM Holladay Report

[Technical meeting] SMILE Treatment developer visited EYEREUM

2018.12.07 4768

Dr. Mark Bischoff (R&d director) and Ronald Wendenburg(Product director) 

from Carl ZEISS Headquarter visited EYEREUM.




▲ Dr. JinHyoung Kim and Carl Zeiss directors

The purpose of visiting was for observing 

EYEREUM's Low Energy SMILE Treatment and technical consultation. 


▼ Dr. David Sung Yong Kang 

We hope this meeting will contribute to further the evolution of SMILE treatment!

EYEREUM always try to make your eye surgery safer. 

By globalization of Low Energy SMILE, 

We will provide safe surgery for foreign patients as well as Koreans.



EYEREUM OPHTHALMIC CLINIC

EYEREUM OPHTHALMIC CLINIC™